Open-label, Randomized, Single Center, Paralleled Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Latest Information Update: 22 Aug 2019
At a glance
- Drugs Olmesartan medoxomil/rosuvastatin (Primary) ; Angiotensin inhibitors; HMG-CoA reductase inhibitors
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
Most Recent Events
- 21 Aug 2019 New trial record